|Journal of the Pancreas is believed to publish the most authenticated review articles on Autoimmune pancreatitis. With the support of eminent editorial board and efficient reviewers entire peer-reviewing process is done through editorial manager system which assures the publication of high quality articles about Autoimmune pancreatitis.
Autoimmune pancreatitis (AIP) is a newly discovered type of chronic pancreatitis that can be difficult to distinguish from pancreatic carcinoma. Autoimmune pancreatitis (AIP) is found to responds to treatment with corticosteroids, especially prednisone. Nowadays it is regarded as a form of hyper-IgG4 disease. There are two categories of AIP: Types 1 and Type 2 each with different clinical profiles. Type 1 AIP patients tended to be older and have a high relapse rate, but patients with Type 2 AIP do not experience relapse and tend to be younger. AIP does not affect long-term survival.
OMICS Group, the leading online open access publisher systematically maintains more than 700+ peer-reviewed journals, Journal of the pancreas being one among them are supported by very efficient editorial board and have more than 3 millionâs reader database. The other wing of OMICS International, OMICS Group conferences, successfully organizes around 3000+ International Scientific Conferences annually on emerging research topics in the fields of medical, clinical, engineering and life sciences.